IL17A and type 1 diabetes mellitus: IL-17 cytokines are also involved in the initiation of autoimmunity in rheumatoid arthritis, experimental autoimmune encephalomyelitis, multiple sclerosis, systemic lupuserythematosus, and auto-immune diabetes (T1DM) [ 9 - 12 ].The risks of T1DM are ALA-associated genotypes and B cell autoantibodies.